Product verification: This description is based on the supplied identification, Celkeran 2 mg (Chlorambucil). Confirm the exact manufacturer, formulation, pack size, approved indications, and storage conditions before publishing.
Important Safety Warning: Chlorambucil is a cytotoxic chemotherapy medicine that can cause severe bone marrow suppression, serious infections, bleeding, infertility, fetal harm, and secondary cancers. It must be prescribed and monitored by a healthcare professional experienced in cancer treatment.
What Is Celkeran 2 mg?
Celkeran 2 mg is an oral chemotherapy medicine containing chlorambucil, an alkylating antineoplastic agent used in selected blood and lymphatic system cancers.
Chlorambucil belongs to the nitrogen mustard family of chemotherapy medicines.
It works by damaging the DNA of susceptible cells, interfering with their ability to replicate and divide.
This action may slow the growth of certain cancer cells and help control selected hematological malignancies.
Chlorambucil has historically been used in the treatment of chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and certain non-Hodgkin lymphomas.
However, modern oncology treatment has evolved, and targeted therapies, immunotherapies, and other regimens are now preferred for many patients.
The 2 mg tablet strength allows oncology specialists to construct individualized treatment regimens. It does not represent a universally recommended daily dose.
Common Reasons for Prescribing Celkeran 2 mg
- Selected chronic lymphocytic leukemia treatment regimens
- Certain indolent non-Hodgkin lymphomas
- Selected historical or specialist-directed Hodgkin lymphoma regimens
- Certain lymphoproliferative disorders
- Selected patients requiring oral alkylating chemotherapy
- Specialist-directed hematological cancer treatment protocols
Important: Chlorambucil is not appropriate for every leukemia, lymphoma, or solid tumor. Treatment must be based on the confirmed diagnosis and current oncology guidance.
How Does Celkeran 2 mg Work?
1. Acts as an Alkylating Agent
Chlorambucil is a nitrogen mustard alkylating agent that interferes with cellular DNA.
2. Forms Reactive Chemical Compounds
After administration, chlorambucil and its active metabolites can interact with genetic material.
3. Produces DNA Cross-Links
Chlorambucil can form cross-links within or between DNA strands.
4. Disrupts DNA Replication
DNA damage interferes with the ability of cells to copy their genetic material.
5. Interferes With Cell Division
Cells with substantial DNA damage may be unable to divide normally.
6. Promotes Cancer Cell Death
Accumulated DNA damage can activate pathways leading to cell death.
7. Affects Healthy Cells
Chlorambucil also affects healthy cells, especially blood-forming cells in the bone marrow.
This contributes to adverse effects such as anemia, neutropenia, and thrombocytopenia.
Important: Chlorambucil is not selective for cancer cells alone. Its effects on healthy tissues require careful dose management and monitoring.
Uses of Celkeran 2 mg
1. Chronic Lymphocytic Leukemia (CLL)
Chlorambucil has been used to treat chronic lymphocytic leukemia, a cancer involving certain lymphocytes.
It may reduce abnormal lymphocyte populations and help control disease-related symptoms.
Modern targeted therapies are generally preferred for many patients with CLL.
2. Non-Hodgkin Lymphoma
Chlorambucil may be used in selected non-Hodgkin lymphoma regimens.
Its role depends on the lymphoma subtype, disease stage, patient characteristics, and treatment availability.
3. Follicular Lymphoma
Chlorambucil has historically been used in certain indolent lymphomas, including follicular lymphoma.
Current treatment approaches frequently involve other therapies.
4. Hodgkin Lymphoma
Chlorambucil has historical use in selected Hodgkin lymphoma regimens.
It is not a routine first-line treatment in modern Hodgkin lymphoma care.
5. Other Indolent Lymphoproliferative Disorders
An oncology specialist may consider chlorambucil for selected lymphoproliferative disorders when clinically appropriate.
6. Disease Control in Selected Patients
Chlorambucil may help control susceptible hematological malignancies in patients for whom it remains an appropriate option.
7. Reduction of Abnormal Lymphocyte Burden
Its cytotoxic effects may reduce abnormal lymphocyte populations in responsive diseases.
8. Specialist-Directed Combination Treatment
Chlorambucil has been used in combination with certain other anticancer medicines.
Combination therapy must follow an established oncology protocol.
9. Selected Historical Non-Oncology Uses
Chlorambucil has historically been used off-label for certain severe immune-mediated disorders.
Because of its toxicity and the availability of alternative treatments, such use requires exceptional specialist justification.
10. Individualized Hematological Cancer Management
An oncologist may prescribe chlorambucil when its expected benefits outweigh its risks and it remains appropriate under current clinical guidance.
Important: Chlorambucil is not a universal anticancer medicine and should not be advertised as a cure for leukemia, lymphoma, or other cancers.
Celkeran 2 mg Dosage and Administration
Chlorambucil dosing must be determined by an oncology specialist.
The prescribed regimen depends on the cancer type, treatment protocol, body weight or other dosing parameters, blood counts, treatment response, and toxicity.
General Dosage Information
| Dosage Information | Details |
|---|---|
| Tablet Strength | 2 mg |
| Active Ingredient | Chlorambucil |
| Administration Route | Oral |
| Adult Dosage | Individualized according to the oncology protocol |
| Treatment Frequency | May involve daily or intermittent dosing depending on the regimen |
| Treatment Duration | Determined by disease response and toxicity |
| Dose Adjustments | May be necessary for low blood counts or other adverse effects |
| Pediatric Use | Requires specialist assessment |
| Medical Supervision | Essential throughout treatment |
Important: The 2 mg tablet strength is not a recommended daily dose. Incorrect chlorambucil dosing may cause life-threatening toxicity.
General Administration Instructions
- Take Celkeran only according to the oncologist’s written instructions.
- Confirm the exact dose and scheduled treatment days.
- Swallow the tablet whole with water.
- Do not crush, chew, or split cytotoxic tablets unless an oncology pharmacy specifically authorizes a safe method.
- Follow product-specific instructions regarding food.
- Do not take additional doses.
- Do not change the treatment schedule independently.
- Attend all required blood tests.
- Inform the oncology team about fever, bleeding, unusual bruising, or severe weakness.
- Follow cytotoxic medicine handling and storage instructions.
- Keep tablets away from children and pets.
- Ask the oncology pharmacy how to dispose of unused tablets.
Should Celkeran 2 mg Be Taken With Food?
Administration instructions depend on the exact product and treatment protocol.
Some chlorambucil products are recommended on an empty stomach.
Follow the oncology team’s instructions.
What If a Dose Is Missed?
Contact the oncology team for instructions.
Do not double the next dose or independently alter the chemotherapy schedule.
What If Too Much Celkeran Is Taken?
An overdose may cause severe bone marrow suppression, neurological toxicity, and other serious complications.
Seek emergency medical attention immediately.
Can Celkeran Be Stopped Suddenly?
Do not independently stop or modify the prescribed treatment.
An oncologist may interrupt, reduce, or discontinue therapy based on blood counts, treatment response, or toxicity.
How Long Does Celkeran 2 mg Take to Work?
Chlorambucil begins affecting susceptible cells after administration, but the clinical response is not immediate.
The time required to observe treatment benefits varies according to the malignancy, disease burden, treatment schedule, and individual response.
Oncologists assess effectiveness through clinical examinations, blood counts, imaging when indicated, and disease-specific investigations.
Treatment response may be evaluated over several weeks or treatment cycles.
Patients should not judge treatment effectiveness solely by whether symptoms improve immediately.
Common Side Effects
Possible side effects include:
- Nausea
- Vomiting
- Reduced appetite
- Fatigue
- Weakness
- Diarrhea
- Mouth irritation
- Anemia
- Low white blood cell count
- Low platelet count
- Increased infection susceptibility
- Unusual bruising
- Skin rash
The likelihood and severity of adverse effects depend on the treatment regimen, cumulative exposure, and individual patient factors.
Potentially Harmful Effects & Serious Health Risks
1. Bone Marrow Suppression
Chlorambucil can suppress the production of red blood cells, white blood cells, and platelets.
2. Neutropenia
A reduced neutrophil count increases the risk of serious infections.
3. Thrombocytopenia
Low platelet counts may cause bruising or bleeding.
4. Anemia
Reduced red blood cell production may cause fatigue, weakness, and shortness of breath.
5. Serious Infections
Patients receiving chlorambucil may develop severe infections, particularly when blood counts are low.
6. Secondary Malignancies
Chlorambucil can increase the risk of secondary cancers, including treatment-related leukemia.
7. Infertility
Chlorambucil may impair fertility in both males and females, sometimes permanently.
8. Fetal Harm
Chlorambucil can cause fetal harm and should be avoided during pregnancy unless a specialist determines that treatment is essential under exceptional circumstances.
9. Seizures
Seizures and other neurological complications have been reported.
10. Severe Skin Reactions
Rare but serious reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, may occur.
11. Pulmonary Toxicity
Rare pulmonary complications, including interstitial pneumonitis and pulmonary fibrosis, have been reported.
12. Liver Injury
Liver-related adverse effects may occur and require clinical assessment.
13. Severe Gastrointestinal Toxicity
Nausea, vomiting, and other gastrointestinal symptoms may become significant in some patients.
14. Allergic Reactions
Hypersensitivity reactions, including serious skin or systemic reactions, may occur.
15. Cumulative Toxicity
Repeated exposure can increase the risk of bone marrow suppression, infertility, and certain long-term complications.
Emergency warning: Patients receiving chlorambucil should seek urgent medical assessment for fever of 38°C (100.4°F) or higher, chills, unusual bleeding, severe shortness of breath, seizures, or a widespread blistering rash.
Contraindications & Safety Precautions
1. Allergy to Chlorambucil
Do not take Celkeran if allergic to chlorambucil or another product ingredient.
2. Previous Resistance to Chlorambucil
Chlorambucil should not be used when the disease has demonstrated resistance and the treating specialist determines that it is inappropriate.
3. Severe Bone Marrow Suppression
Patients with significantly reduced blood counts require careful assessment before treatment.
4. Active Infections
Infections should be evaluated before and during chemotherapy.
5. Pregnancy
Chlorambucil can harm an unborn baby. Pregnancy must be avoided during treatment.
6. Breastfeeding
Breastfeeding is not recommended during chlorambucil treatment because of the potential for serious harm to the infant.
7. Fertility Concerns
Patients should discuss fertility preservation before starting treatment when appropriate.
8. Contraception
Patients who can become pregnant or cause pregnancy should follow the oncology team’s contraception recommendations during and after treatment.
The required duration depends on the applicable product guidance and individual circumstances.
9. Liver Disease
Patients with significant liver impairment may require dose adjustment or additional monitoring.
10. Kidney Disease
Patients with kidney disease should inform the oncology team so overall treatment safety can be assessed.
11. Previous Chemotherapy
Prior cytotoxic treatment may increase the risk of cumulative bone marrow toxicity.
12. Previous Radiation Therapy
Radiation exposure may affect bone marrow reserve and treatment tolerance.
13. Seizure Disorders
Patients with a history of seizures require careful assessment because chlorambucil may cause neurological toxicity.
14. Live Vaccines
Live vaccines are generally avoided during significant chemotherapy-related immunosuppression.
15. Drug Interactions
Potentially important concerns include:
- Other Cytotoxic Medicines: May increase bone marrow suppression.
- Other Immunosuppressants: May increase infection risk.
- Live Vaccines: May cause serious infection in immunosuppressed patients.
- Medicines Affecting Blood Counts: May increase hematological toxicity.
- Certain Anticancer Combinations: Require protocol-specific monitoring.
- Over-the-Counter Medicines and Supplements: Should be reviewed by the oncology team.
16. Handling Cytotoxic Tablets
Chlorambucil tablets should be handled carefully.
Do not crush or break tablets without specific pharmacy instructions.
Pregnant individuals should avoid handling damaged cytotoxic tablets.
17. Refrigerated Storage
Many chlorambucil tablet products require storage at 2–8°C.
Do not freeze unless the manufacturer specifically instructs otherwise.
Confirm the exact storage requirements for Celkeran.
18. Medical Monitoring
Healthcare professionals may monitor:
- Complete blood count
- Neutrophil count
- Platelet count
- Hemoglobin
- Liver function
- Kidney function
- Infection symptoms
- Bleeding symptoms
- Neurological symptoms
- Skin reactions
- Pulmonary symptoms
- Disease response
- Cumulative treatment exposure
- Fertility-related concerns
- Need for dose interruption or adjustment
Advantages
- Established alkylating chemotherapy agent.
- Oral administration.
- Activity against selected hematological malignancies.
- Historical use in chronic lymphocytic leukemia.
- Use in selected lymphoma treatment regimens.
- May reduce abnormal lymphocyte populations.
- May help control susceptible disease.
- Can be incorporated into individualized oncology protocols.
- 2 mg strength supports flexible prescribed dosing.
- Extensive historical clinical experience.
- May remain an option for selected patients when clinically appropriate.
Disadvantages / Limitations
- Can cause severe bone marrow suppression.
- Increases infection risk.
- May cause anemia.
- May cause thrombocytopenia.
- May cause serious bleeding.
- May cause nausea.
- May cause vomiting.
- May cause fatigue.
- May cause severe skin reactions.
- May cause seizures.
- May cause pulmonary toxicity.
- May cause infertility.
- Can harm an unborn baby.
- May increase the risk of secondary malignancies.
- Requires regular blood tests.
- Requires specialist oncology supervision.
- May require refrigerated storage.
- Requires careful cytotoxic handling.
- Not suitable for self-medication.
- Not appropriate for every cancer type.
- Newer treatments may be preferred for many patients.
Important Notes
Generic Name: Chlorambucil.
Brand Name: Celkeran.
Strength: 2 mg.
Drug Class: Alkylating Antineoplastic Agent.
Therapeutic Category: Chemotherapy / Anticancer Medicine.
Primary Uses: Selected chronic lymphocytic leukemia and lymphoma treatment regimens.
Mechanism: DNA alkylation and cross-link formation.
Administration Route: Oral.
Dosage: Individualized by an oncology specialist.
Major Warning: Severe bone marrow suppression, infections, bleeding, infertility, fetal harm, and secondary malignancies.
Pregnancy Warning: Can cause fetal harm.
Breastfeeding Warning: Breastfeeding is not recommended during treatment.
Fertility Warning: May cause permanent infertility.
Monitoring: Regular blood counts and clinical assessment.
Prescription Status: Prescription-Only Cytotoxic Medicine.
Storage: Follow product-specific instructions; refrigeration is commonly required.
Frequently Asked Questions
1. What is Celkeran 2 mg used for?
Celkeran 2 mg contains chlorambucil, a chemotherapy medicine used in selected treatment regimens for chronic lymphocytic leukemia and certain lymphomas.
2. What is the generic name of Celkeran?
The generic name is chlorambucil.
3. Is Celkeran 2 mg a chemotherapy medicine?
Yes. Chlorambucil is a cytotoxic alkylating chemotherapy medicine.
4. How does Celkeran work?
It damages cellular DNA through alkylation and cross-link formation, interfering with cell division and survival.
5. Can Celkeran treat chronic lymphocytic leukemia?
Chlorambucil has been used for CLL, although modern targeted treatments are preferred for many patients.
6. Can Celkeran treat lymphoma?
It may be used in selected lymphoma treatment regimens depending on the subtype and clinical circumstances.
7. Is Celkeran suitable for every cancer?
No. Chlorambucil is used for specific conditions and is not appropriate for all cancer types.
8. How should Celkeran 2 mg be taken?
Take it orally exactly according to the oncologist’s prescribed treatment schedule.
9. Can Celkeran tablets be crushed?
Cytotoxic tablets should not be crushed, chewed, or split unless the oncology pharmacy specifically authorizes a safe method.
10. Does Celkeran require blood tests?
Yes. Regular blood count monitoring is essential because chlorambucil can cause severe bone marrow suppression.



































































Mateo (verified owner) –
No side effects, just stronger immunity and better health.
Mason (verified owner) –
Viral Care is a game-changer for my immune support.